Speaker

Martin Hey-Mogensen

Director, Novo Nordisk A/S

Martin Hey-Mogensen, Director, Novo Nordisk A/S, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Exploring Energy Expenditure as an Alternative Method of Obesity Treatment”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- SpeakerExploring Energy Expenditure as an Alternative Method of Obesity Treatment
- PanelPanel & Audience Discussion: Evaluating Oral, Injectable & DNA Delivery Methods to Align Modality Selection with Clinical Performance & Commercial Scale

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Martin Hey-Mogensen, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].